Oric Pharmaceuticals, Inc. ORIC Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$35.77M-17.2% | -$30.51M+6.4% | -$32.59M+10.4% | -$36.36M-21.1% | -$30.02M+17.3% | ||
| $270K-15.6% | $320K+11.1% | $288K-7.1% | $310K+2.6% | $302K-0.7% | ||
| $6.9M+9.9% | $6.28M+11.5% | $5.63M-14.3% | $6.57M+0.3% | $6.55M+26.0% | ||
| -$3.32M-642% | -$448K— | —— | -$248K+96.9% | -$7.91M-361% | ||
| $679K+132% | -$2.11M-170% | -$782K-247% | $532K-7.5% | $575K+142% | ||
| -$32.44M-44.3% | -$22.48M+10.5% | -$25.11M+18.6% | -$30.84M+5.2% | -$32.53M-16.0% | ||
| $2K-99.1% | $227K+549% | $35K-44.4% | $63K-83.7% | $387K+76.7% | ||
| $77.97M+72.2% | $45.29M-72.6% | $165.5M+33.1% | $124.37M+92.3% | $64.66M+86.7% | ||
| -$17.98M— | —— | -$110.54M-43.7% | -$76.93M-443% | $22.45M-47.4% | ||
| $60.88M— | $0-100% | $110.44M-17.5% | $133.93M— | $0— | ||
| $61.14M+3,976% | $1.5M-98.6% | $109.45M-18.5% | $134.3M+1,220,827% | $11K-98.1% | ||
| $10.73M+368% | -$4M+84.7% | -$26.2M-199% | $26.53M+363% | -$10.07M-166% | ||
| -$162K-168% | $240K-59.1% | $587K-0.7% | $591K-33.0% | $882K-46.0% | ||
| $270K-15.6% | $320K+11.1% | $288K-7.1% | $310K+2.6% | $302K-0.7% | ||
| $679K+132% | -$2.11M-170% | -$782K-247% | $532K-7.5% | $575K+142% | ||
| —— | —— | —— | —— | -$242K— | ||
| $993K— | $0-100% | $1.74M+165% | $656K— | $0— | ||
| -$32.44M-42.8% | -$22.71M+9.7% | -$25.15M+18.6% | -$30.91M+6.1% | -$32.92M-16.4% | ||
| -$32.44M-42.8% | -$22.71M+9.7% | -$25.15M+18.6% | -$30.91M+6.1% | -$32.92M-16.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Oric Pharmaceuticals, Inc. generate?
- Oric Pharmaceuticals, Inc. (ORIC) generated -$110.9M in operating cash flow over the trailing twelve months.
- What is Oric Pharmaceuticals, Inc.'s free cash flow?
- After $327.0K of capital expenditures, Oric Pharmaceuticals, Inc.'s free cash flow was -$111.2M over the trailing twelve months, up 4.4% year over year.
- Where does Oric Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Oric Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.